Radical gastrectomy for gastric cancer at Tata Memorial Hospital

被引:14
作者
Bhandare, Manish S. [1 ]
Kumar, Naveena A. N. [1 ]
Batra, Swati [1 ]
Chaudhari, Vikram [1 ]
Shrikhande, Shailesh, V [1 ]
机构
[1] Tata Mem Hosp, Dept Surg Oncol, GI & HPB Serv, Bombay, Maharashtra, India
关键词
D2; lymphadenectomy; gastric cancer; gastrectomy; PERIOPERATIVE CHEMOTHERAPY; STAGING LAPAROSCOPY; OXALIPLATIN;
D O I
10.4103/ijc.IJC_665_17
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM: Tata Memorial Hospital is one of the high-volume tertiary care referral centers for gastric cancer (GC) in India. We aimed to analyze the outcomes after surgery for GC. PATIENTS AND METHODS: Data were collected from the prospective database maintained by the Gastrointestinal and Hepato-Pancreato-Biliary Division of the Department of Surgical Oncology at Tata Memorial Hospital, Mumbai, Maharashtra, India. All consecutive patients who underwent curative resection for adenocarcinoma of the stomach from January 2010 to December 2015 were included. RESULTS: A total of 580 patients underwent curative resection for adenocarcinoma of the stomach in the above mentioned time span. Distal tumors were more common and the tumor epicenter was at the distal body/antrum in 435 (75%) patients. One hundred eighty-two (31.3%) patients underwent upfront surgery and 398 patients (68.6%) were operated after receiving neoadjuvant chemotherapy. Surgical procedures included 371 distal/subtotal gastrectomies, 78 proximal, and 131 total gastrectomies. Overall median blood loss was 500 mL and intraoperative blood transfusion was required only in 10.5%. Median hospital stay was 8 days (range, 3-44). Postoperative major morbidity (Clavein-Dindo grade III/IV) was 8.9% and mortality was 1.5%. Median lymph node yield was 18 (range, 2-76). When perioperative outcomes were compared in the initial half of the study period (Period 1, 2010-2012) versus the later half (Period 2, 2013-2015), the median lymph node yield was found to be better in the later half (17 vs. 19) along with reduction in the median hospital stay (16 vs. 11 days). At a median follow-up of 36 months (range, 3-225 months), overall 5-year survival was 51.9%. The disease-free survival at 5 years was 46.9%. CONCLUSION: Results from our study indicate that, with increasing hospital volumes, the median lymph node yield after D2 gastrectomy improves and the median hospital stay is reduced. Surgery for GCs in high-volume centers might result in improved perioperative outcomes.
引用
收藏
页码:605 / 608
页数:4
相关论文
共 12 条
[1]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20
[2]   Epidemiological review of gastric cancer in India [J].
Dikshit, Rajesh P. ;
Mathur, Garima ;
Mhatre, Sharayu ;
Yeole, B. B. .
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2011, 32 (01) :3-11
[3]   Yield of Staging Laparoscopy for Incurable Factors in Chinese Patients with Advanced Gastric Cancer [J].
Huang, Jun ;
Luo, Hongliang ;
Zhou, Chengliang ;
Zhan, Jianjun ;
Rao, Xionghui ;
Zhao, Gang ;
Zhu, Zhengming .
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2018, 28 (01) :19-24
[4]   Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan [J].
Irino, Tomoyuki ;
Sano, Takeshi ;
Hiki, Naoki ;
Ohashi, Manabu ;
Nunobe, Souya ;
Kumagai, Koshi ;
Ida, Satoshi ;
Yamaguchi, Toshiharu .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (01) :268-275
[5]   Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893] [J].
Kim, Hyoung-Il ;
Hur, Hoon ;
Kim, Youn Nam ;
Lee, Hyuk-Joon ;
Kim, Min-Chan ;
Han, Sang-Uk ;
Hyung, Woo Jin .
BMC CANCER, 2014, 14
[6]   Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial [J].
Noh, Sung Hoon ;
Park, Sook Ryun ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Chung, Ik-Joo ;
Kim, Sang-Woon ;
Kim, Hyung-Ho ;
Choi, Jin-Hyuk ;
Kim, Hoon-Kyo ;
Yu, Wansik ;
Lee, Jong Inn ;
Shin, Dong Bok ;
Ji, Jiafu ;
Chen, Jen-Shi ;
Lim, Yunni ;
Ha, Stella ;
Bang, Yung-Jue .
LANCET ONCOLOGY, 2014, 15 (12) :1389-1396
[7]   Gastric cancer in India [J].
Sharma, Atul ;
Radhakrishnan, Venkatraman .
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2011, 32 (01) :12-16
[8]   D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials [J].
Shrikhande, Shailesh V. ;
Shukla, Parul J. ;
Qureshi, Sajid ;
Siddachari, Ravichand ;
Upasani, Vivek ;
Ramadwar, Mukta ;
Kakade, Anagha C. ;
Hawaldar, Rohini .
DIGESTIVE SURGERY, 2006, 23 (03) :192-197
[9]   Indian Council of Medical Research consensus document for the management of gastric cancer [J].
Shrikhande, Shailesh V. ;
Sirohi, Bhawna ;
Barreto, Savio G. ;
Chacko, Raju T. ;
Parikh, Purvish M. ;
Pautu, Jeremy ;
Arya, Supreeta ;
Patil, Prachi ;
Chilukuri, Srinivas C. ;
Ganesh, B. ;
Kaur, Tanvir ;
Shukla, Deepak ;
Rath, Goura Shankar .
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2014, 35 (04) :239-243
[10]   Epirubicin, oxaliplatin, and capectabine is just as "MAGIC"al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer [J].
Sirohi, Bhawna ;
Barreto, Savio George ;
Singh, Ashish ;
Batra, Swati ;
Mittra, Abhishek ;
Rastogia, Sameer ;
Ramadwar, Mukta ;
Shetty, Nitin ;
Goel, Mahesh ;
Shrikhande, Shailesh V. .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) :866-870